New advances in research of effect of chronic kidney disease-mineral and bone disorder on sarcopenia

doi:10.3877/cma.j.issn.1674-0785.2025.01.011

Abstract

Abstract:

Chronic kidney disease-mineral and bone disorder （CKD-MBD） and sarcopenia are common complications of end-stage renal disease. The main characteristics of sarcopenia are reduced muscle mass and reduced strength. Recent studies have suggested that CKD-MBD may increase the incidence of sarcopenia. However， the relationship between CKD-MBD and sarcopenia is not clear. Tle reviews the research on the impact of CKD-MBD on sarcopenia in patients.

Key words: Chronic kidney disease-mineral and bone disorder, Sarcopenia, Chronic kidney disease

Ziyi Cao, Jiajun Zhou. New advances in research of effect of chronic kidney disease-mineral and bone disorder on sarcopenia[J]. Chinese Journal of Clinicians(Electronic Edition), 2025, 19(01): 75-79.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2025.01.011

https://zhlcyszz.cma-cmc.com.cn/EN/Y2025/V19/I01/75

References 45

1	Cruz-Jentoft AJ， Bahat G， Bauer J， et al. Sarcopenia： revised European consensus on definition and diagnosis ［J］. Age Ageing， 2019， 48（4）：601.
2	Jansson KP， Yu ASL， Stubbs JR. Contribution of phosphate and FGF23 to CKD progression ［J］. Curr Opin Nephrol Hypertens， 2022， 3（4）：306-311.
3	Mazzaferro S， Bagordo D， De Martini N， et al. Inflammation， oxidative stress， and bone in chronic kidney disease in the osteoimmunology era［J］. Calcif Tissue Int， 2021， 108（4）：452-460.
4	Wheeler DC， Winkelmayer WC. KDIGO 2017 clinical practice guideline update for the diagnosis， evaluation， prevention， and treatment of chronic kidney disease-mineral and bone disorder （CKDMBD） foreword ［J］. Kidney Int Suppl， 2017， 7（1）： 1-4.
5	Hu L， Napoletano A， Provenzano M， et al. Mineral bone disorders in kidney disease patients： The ever-current topic ［J］. Int J Mol Sci， 2022，23（20）： 12223.
6	Wong L， Duque G， McMahon LP. Sarcopenia and frailty： challenges in mainstream nephrology practice ［J］. Kidney Int Rep， 202， 6（10）： 2554-2564.
7	王家圆，王晓东. 消化系统恶性肿瘤相关肌少症的研究进展［J/OL］. 中华临床医师杂志（电子版）， 2023， 17（7）： 823-827.
8	Mellen RH， Girotto OS， Marques EB， et al. Insights into pathogenesis，nutritional and drug approach in sarcopenia： A systematic review ［J］.Biomedicines， 2023， 11（1）： 136..
9	Cho MR， Lee S， Song SK. A review of sarcopenia pathophysiology，diagnosis， treatment and future direction ［J］. J Korean Med Sci， 2022，37（8）： e46.
10	Yu MD， Zhang HZ， Zhang Y， et al. Relationship between chronic kidney disease and sarcopenia ［J］. Sci Rep， 2021， 11（1）： 20523.
11	Ribeiro HS， Neri SGR， Oliveira JS， et al. Association between sarcopenia and clinical outcomes in chronic kidney disease patients： A systematic review and meta-analysis ［J］. Clin Nutr， 2022， 41（5）： 1131-1140.
12	Zhang XM， Luo Z， Xie XM， et al. Comment on “Prevalence of sarcopenia in patients with chronic kidney disease： a global systematic review and meta-analysis” ［J］. J Cachexia Sarcopenia Muscle， 2024，15（4）： 1621-1623.
13	Verzola D， Bonanni A， Sofia A， et al. Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease ［J］. J Cachexia Sarcopenia Muscle， 2017， 8（1）： 131-144.
14	Raj DS， Sun Y， Tzamaloukas AH. Hypercatabolism in dialysis patients［J］. Curr Opin Nephrol Hypertens， 2008， 17（6）： 589-594.
15	Kidney Disease： Improving Global Outcomes （KDIGO） CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis， evaluation， prevention， and treatment of chronic kidney disease-mineral and bone disorder （CKD-MBD）［J］. Kidney Int Suppl （2011）， 2017， 7（1）： 1-59.
16	Wang XH， Mitch WE. Mechanisms of muscle wasting in chronic kidney disease ［J］. Nat Rev Nephrol， 204， 10（9）： 504-516.
17	杨海明，孟宪杰，吴薇，等. CKD-MBD患者血清骨代谢标记物与中医证候特征的回归分析［J］. 中国中药杂志， 207， 42（20）： 4027-4034.
18	Wang Y， Ma W， Pu J， et a. Interrelationships between sarcopenia，bone turnover markers and low bone mineral density in patients on hemodialysis ［J］. Ren Fail， 2023， 45（1）： 2200846.
19	Kaur R， Singh R. Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications ［J］. Life Sci， 2022，311（Pt B）： 121148.
20	Sosa P， Alcalde-Estévez E， Asenjo-Bueno A， et al. Aging-related hyperphosphatemia impairs myogenic differentiation and enhances fibrosis in skeletal muscle ［J］. J Cachexia Sarcopenia Muscle， 2021，12（5）： 266-279.
21	Evenepoel P， Bover J， Ureña Torres P. Parathyroid hormone metabolism and signaling in health and chronic kidney disease ［J］.Kidney Int， 2016， 90（6）： 1184-1190.
22	Murthy LS， de França NAG， Duval GT ，et al. Higher concentrations of parathyroid hormone （PTH） are associated with reduced gait velocity in adults： A systematic review ［J］. Arch Gerontol Geriatr， 2022， 99：104579.
23	Kir S， Komaba H， Garcia AP， et al. PTH/PTHrP receptor mediates cachexia in models of kidney failure and cancer ［J］. Cell Metab， 2016，23（2）： 315-323.
24	Kidney Disease： Improving Global Outcomes （KDIGO） CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis，evaluation， prevention， and treatment of Chronic Kidney Disease-Mineral and Bone Disorder （CKD-MBD）［J］. Kidney Int Suppl， 2009，（113）： S1-130
25	Sha T， Wang Y， Zhang Y， et al. Genetic variants， serum 25-hydroxyvitamin D levels， and sarcopenia： A mendelian randomization analysis ［J］. JAMA Netw Open， 2023， 6（8）： e233558.
26	Remelli F， Vitali A， Zurlo A， et al. Vitamin D deficiency and sarcopenia in older persons ［J］. Nutrients， 2019， 11（12）： 2861.
27	Brandenburg V， Ketteler M. Vitamin D and secondary hyperparathyroidism in chronic kidney disease： A critical appraisal of the past， present， and the future ［J］. Nutrients， 2022， 14（15）： 3009.
28	Pilz S， Kienreich K， Rutters F， et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes ［J］. Curr Diab Rep， 2013， 13（2）： 261-270.
29	Acevedo LM， Vidal Á， Aguilera-Tejero E， et al. Muscle plasticity is influenced by renal function and caloric intake through the FGF23-vitamin D axis ［J］. Am J Physiol Cell Physiol， 2023， 324（1）： C4-C28.
30	Yu LX， Li SS， Sha MY， et al. The controversy of klotho as a potential biomarker in chronic kidney disease ［J］. Front Pharmacol， 2022， 13：931746.
31	Buchanan S， Combet E， Stenvinkel P， et al. Klotho， aging， and the failing kidney ［J］. Front Endocrinol （Lausanne）， 2020， 11： 560.
32	Kale A， Sankrityayan H， Anders HJ， et al. Epigenetic and nonepigenetic regulation of Klotho in kidney disease ［J］. Life Sci， 2021，264： 118644.
33	Aguilar A， Gifre L， Ureña-Torres P， et al. Pathophysiology of bone disease in chronic kidney disease： from basics to renal osteodystrophy and osteoporosis ［J］. Front Physiol， 2023， 14： 1177829.
34	Aucella F， Amicone M， Perez Ys ADM， et al. Does physical exercise ameliorate chronic kidney disease-related complications? The case of anaemia and chronic kidney disease-mineral bone disorder ［J］. Kidney Blood Press Res， 2024， 49（1）： 812-820.
35	周婷婷，冯正平. 骨代谢指标在慢性肾脏病-矿物质骨代谢紊乱中的研究进展［J］. 中华骨质疏松和骨矿盐疾病杂志， 2019， 12（3）：311-316.
36	Waziri B， Duarte R， Naicker S. Chronic kidney disease-mineral and bone disorder （CKD-MBD）： current perspectives ［J］. Int J Nephrol Renovasc Dis， 2019， 12： 263-276.
37	Hu L， Napoletano A， Provenzano M. Mineral bone disorders in kidney disease patients： The ever-current topic ［J］. Int J Mol Sci， 2022，23（20）： 12223.
38	刘章锁. 维持性血液透析患者蛋白质能量消耗与矿物质代谢紊乱的关系［J］. 中国实用内科杂志， 2019， 39（11）： 930-932.
39	李林雪，朱亦堃. 肌肉减少症与维生素D关系的研究进展［J/OL］.中华临床医师杂志（电子版）， 2021， 15（1）： 61-64.
40	Ammirati AL. Chronic kidney disease ［J］. Rev Assoc Med Bras （1992），2020， 66Suppl 1 （Suppl 1）： s03-s09.
41	Yamada S， Nakano T. Role of Chronic Kidney Disease （CKD）-Mineral and Bone Disorder （MBD） in the Pathogenesis of Cardiovascular Disease in CKD ［J］. J Atheroscler Thromb， 2023， 30（8）： 835-850.
42	Bakinowska E， Olejnik-Wojciechowska J， Kiebowski K， et al.Pathogenesis of sarcopenia in chronic kidney disease-The role of inflammation， metabolic dysregulation， gut dysbiosis， and microRNA［J］. Int J Mol Sci， 2024， 25（15）： 8474.
43	Patschan D， Patschan S， Ritter O. Chronic metabolic acidosis in chronic kidney disease ［J］. Kidney Blood Press Res， 2020， 45（6）： 812-822.
44	Arefin S， Buchanan S， Hobson S， et al. Nrf2 in early vascular ageing：calcification， senescence and therapy ［J］. Clin Chim Acta， 2020， 505：108-118.
45	Martin A， Kentrup D. The role of DMP in CKD-MBD ［J］. Curr Osteoporos Rep， 2021， 19（5）： 500-509.

[1]	Xiaoqing Tang, Ping He, You Yang, Xia Luo, Juying Zhang, Xin Yang, Jinhong Yu. Correlation of sound touch elastography combined with pulsed wave Doppler ultrasound imaging parameters with stage of early chronic kidney disease and their clinical significance [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(05): 491-499.
[2]	Yabin Guo, Yang Zhou, Xiaotong Liu, Yang Zhou, Boya Wang, Biyun Zeng. Scoping review of studies on sarcopenia in total joint replacement patients [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2024, 18(06): 765-772.
[3]	Simin Chen, Jie Mao, Xiaoli Du, Shuze Zhang. A comparative study of skeletal muscle mass detected by computed tomography and bioelectrical impedance analysis in gastric cancer patients [J]. Chinese Archives of General Surgery(Electronic Edition), 2025, 19(01): 28-33.
[4]	Ling Xi, Hanwen Tong, Ji Miao, Yonghuan Mao, Xiaofei Shen, Junfeng Du, Ye Liu. Risk factors prediction model of parastostomy hernia based on sarcopenia [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 48-51.
[5]	Transplantation Group, Branch of Organ Transplantation of Chinese Liver, of Organ Transplant Physicians of Chinese Branch. Chinese clinical guideline for the diagnosis and treatment of sarcopenia in liver transplant recipients [J]. Chinese Journal of Transplantation(Electronic Edition), 2024, 18(06): 355-365.
[6]	Zun Chen, Ping Wang, Hua Jin, Meiling Zhou, Qingqing Li, Yonggang Huang. Application of sarcopenia in predicting incisional hernia after colorectal cancer surgery [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(06): 639-644.
[7]	Yongwu1 Yu, Min Xiong, Ling Zhang. New progress in research on drug treatment of chronic kidney disease-mineral and bone disorder [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2025, 14(01): 44-47.
[8]	Bokai Cheng, Guang Yang. Progress of research on application of hyperinsulinemic-euglycemic clamp technique for assessing insulin resistance in patients with chronic kidney disease [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 334-339.
[9]	Rongrong Feng, Xiaole Su, Lihua Wang. Research progress on biological markers related to complication of cardiovascular disease in patients with chronic kidney disease [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(05): 273-278.
[10]	Junnan Guo, Hui Lin, Yilin Ren, Xi Qiao. Progress of research on the role of amino acid metabolism disturbance in the transition from AKI to CKD [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(05): 283-287.
[11]	Chunfeng Liu, Zhaohui Xu, Hongwei Shi, Rong Chen, Tengfei Ma, Pengfei Li, Rong Yuan, Jianrong Chen, Aiming Xu. Diagnosis of sarcopenia in mechanically ventilated patients and its impact on prognosis [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(09): 820-825.
[12]	Peipei Xi, Jiajun Zhou. Progress in research of sarcopenia in patients with chronic kidney disease: pathogenesis, diagnosis, and treatment [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(05): 491-495.
[13]	Guangning Wang, Yujie Li, Kunfan Gao, Huisong Liu. Research progress on the role of short-chain fatty acids in the pathogenesis of sarcopenia [J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2024, 11(04): 31-37.
[14]	Chaojun Wang, Zhaohui Liu. Progress in diagnosis and treatment of sarcopenic obesity [J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2024, 10(04): 269-275.
[15]	Chaojun Wang, Zhiyong Dong, Wan'e Zhao, Songhao Hu, Zhaohui Liu. Influence of sarcopenia on the effect of sleeve gastrectomy in patients with obesity [J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2024, 10(04): 283-287.

Please choose a citation manager

Content to export